To further verify the expression of biomarkers, we used qRT‒PCR to compare the gene expression levels of CEBPD, H4C11, CEBPB, KLF4, and GATA3 in the peripheral blood of normal controls and NAFLD patients. The gene discussed is CEBPD; the disease is metabolic dysfunction-associated steatotic liver disease.